19
Clinical outcomes of cardiac resynchronization therapy with or without defibrillation in non-ischemic cardiomyopathy: impact of left ventricular midwall fibrosis

EP Europace Journal

5 October 2017

Organised by:

Read full article

Contributors

A. Zegard

Author

E. Acquaye

Author

C. Gubran

Author

R.J. Taylor

Author

P.W.X. Foley

Author

F. Umar

Author

K. Patel

Author

J. Panting

Author

H. Marshall

Author

T. Qiu

Author

F. Leyva

Author

You may be interested in

Congress Session

Personalised approaches to devices in heart failure

17 May 2025

Congress Presentation

Microstructural disease and hypoperfusion in dilated cardiomyopathy associate with ventricular arrhythmias and underpin midwall septal fibrosis

30 August 2025

Congress Presentation

Is myocardial fibrosis appropriately assessed by 2D strain derived integrated backscatter?

26 August 2023

Congress Presentation

Prognostic impact of non-ischaemic late gadolinium enhancement in patients with ischaemic cardiomyopathy

12 December 2024

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

19Clinical outcomes of cardiac resynchronization therapy with or without defibrillation in non-ischemic cardiomyopathy: impact of left ventricular midwall fibrosis

EP Europace Journal

Contributors

You may be interested in

ESC 365 is supported by

19
Clinical outcomes of cardiac resynchronization therapy with or without defibrillation in non-ischemic cardiomyopathy: impact of left ventricular midwall fibrosis